학술논문
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients
Document Type
Article
Author
Source
In Journal of Hepatology January 2006 44(1):88-96
Subject
Language
ISSN
0168-8278